PG
Pravin Gadalya Lachake
About Pravin Gadalya Lachake
Data last updated:
Pravin Gadalya Lachake is a Director at Lasa Supergenerics Limited (since 2025). The company operates in Pharma. Lasa Supergenerics Limited reported revenue of ₹147 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 04 Aug 2025 | 2016 | ₹147 Cr (FY 2025) | Active |
Board colleagues of Pravin Gadalya Lachake
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ganesh Suresh Potdar | 11455401 | Lasa Supergenerics Limited | Additional Director |
| Ketan Bhau Songal | 11228418 | Lasa Supergenerics Limited | Director |
| Mitti Mitesh Jain | Lasa Supergenerics Limited | Company Secretary | |
| Omkar Pravin Herlekar | 01587154 | Lasa Supergenerics Limited | Managing Director |
| Rekha Hemant Wakh | 11229667 | Lasa Supergenerics Limited | Director |
| Varsha Pravin Joshi | Lasa Supergenerics Limited | Cfo | |
| Yogesh Hari Ughada | 11230183 | Lasa Supergenerics Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Pravin Gadalya Lachake
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pravin Gadalya Lachake
Pravin Gadalya Lachake currently holds 1 directorship: Lasa Supergenerics Limited (Director, since 04 Aug 2025, revenue ₹147 Cr (FY 2025)).
Pravin Gadalya Lachake was first appointed on 04 Aug 2025 as Director at Lasa Supergenerics Limited.
The current boards of Pravin Gadalya Lachake's companies include Ganesh Suresh Potdar (Lasa Supergenerics Limited), Ketan Bhau Songal (Lasa Supergenerics Limited), Mitti Mitesh Jain (Lasa Supergenerics Limited), Omkar Pravin Herlekar (Lasa Supergenerics Limited), Rekha Hemant Wakh (Lasa Supergenerics Limited), Varsha Pravin Joshi (Lasa Supergenerics Limited), among others.